Overweight & Obesity

Semaglutide reduces excess body fat in people with obesity

In adults with obesity or overweight, weekly treatment with the glucagon-like peptide 1 (GLP1) receptor agonist semaglutide leads to reduced excess body fat and increased lean body mass, according to an industry-sponsored ...

Diseases, Conditions, Syndromes

US halts trials of plasma transfusions for COVID patients

US health experts said Tuesday they are halting clinical trials of convalescent blood plasma in patients with mild to moderate COVID symptoms after preliminary results showed no benefit from the treatment.

Psychology & Psychiatry

Drug eases recovery for those with severe alcohol withdrawal

A drug once used to treat high blood pressure can help alcoholics with withdrawal symptoms reduce or eliminate their drinking, Yale University researchers report Nov. 19 in the American Journal of Psychiatry.

page 18 from 40